Hepatozelluläres Karzinom: Doppelte Immunblockade effektiv in Erstlinie
Crossref DOI link: https://doi.org/10.1007/s15015-026-4553-6
Published Online: 2026-03-18
Published Print: 2026-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schmale, Ine
Text and Data Mining valid from 2026-03-01
Version of Record valid from 2026-03-01
Article History
First Online: 18 March 2026
Free to read: This content has been made available to all.